Vol. 59 No. 4 (2020): Acta Oncologica

Articles

• Centralization of lung cancer surgery in the Netherlands: differences in care and survival of patients with stage I non-small cell lung cancer between hospitals with and without in-house lung cancer surgery

  Julianne Cynthia de Ruiter, David Jonathan Heineman, Adrianus Johannes de Langen, Max Dahele, Ronald Alphons Maria Damhuis, Koen Johan Hartemink

  384-387

  Published: 2020-04-02

  • PDF

• Immune stimulatory effect of anti-EpCAM immunotoxin – improved overall survival of metastatic colorectal cancer patients

  Yvonne Andersson, Else Marit Inderberg, Gunnar Kvalheim, Theodor Malmer Herud, Olav Engebraaten, Kjersti Flatmark

  404-409

  Published: 2020-04-02

  • PDF

• The influence of bevacizumab on the costs of ovarian cancer treatment in routine clinical practice

  Riikka-Liisa K. Vuorinen, Tiina H. Luukkaala, Johanna U. Mäenpää

  453-457

  Published: 2020-04-02

  • PDF

• Demyelinating polyradiculoneuritis in patients with multiple myeloma: the other side of bortezomib-induced neurotoxicity

  Segolene Gendreau, Giulia Berzero, Camille Tafani, Igor Raynouard, Damien Ricard, Jean-Valère Malfuson, Karine Viala, Rabab Debs, Caroline Houillier, Luca Diamanti, Enrico Marchioni, Timothée Lenglet, Maya Ouzegdouh, Kevin Bihan, Laurent Gilardin, Dimitri Psimaras

  484-489

  Published: 2020-04-02

  • PDF

• It is not just about molecules! Optimal cancer care for the future needs more research on external factors

  Roger Henriksson

  373-375

  Published: 2020-04-02

  • PDF

• Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study

  Bram D. Vermeulen, Lukas Bruggeman, Dirk J. Bac, Ruud W. M. Schrauwen, Ludger S. M. Epping, Robert C. H. Scheffer, Adriaan C. I. T. L. Tan, Marcel J. M. Groenen, Rob H. A. Verhoeven, Peter D. Siersema

  410-416

  Published: 2020-04-02

  • PDF

• Limited-duration anti-PD-1 therapy for patients with metastatic melanoma

  Siru Mäkelä, Laura Kohtamäki, Marjut Laukka, Susanna Juteau, Micaela Hernberg

  438-443

  Published: 2020-04-02

  • PDF

• Longitudinal kidney function outcome in aging testicular cancer survivors

  Ragnhild V. Nome, Milada Cvancarova Småstuen, Trine Bjøro, Cecilie E. Kiserud, Sophie D. Fosså

  467-474

  Published: 2020-04-02

  • PDF

• Treatment patterns and survival outcomes for small-cell lung cancer patients – a Swedish single center cohort study

  Salomon Tendler, Yiqiang Zhan, Andreas Pettersson, Rolf Lewensohn, Kristina Viktorsson, Fang Fang, Luigi De Petris

  388-394

  Published: 2020-04-02

• Effects of the recurrence pattern on patient survival following SABR for stage I lung cancer

  Elisabeth Weiss, Xiaoyan Deng, Nitai Mukhopadhyay, Nuzhat Jan

  427-433

  Published: 2020-04-02

  • PDF

• Prognostic factors for cancer patient admitted to a medical intensive care unit

  Camille Baylot, Adrienne Francopoulo, Marine Gross-Goupil, Amandine Quivy, Olivier Guisset, Gilles Hilbert, Eric Frison, Alain Ravaud, Amaury Daste

  458-461

  Published: 2020-04-02

  • PDF

• Immune checkpoint inhibitor-induced myocarditis not visible with cardiac magnetic resonance imaging but detected with PET-CT: a case report

  Otso Arponen, Tanja Skyttä

  490-492

  Published: 2020-04-02

  • PDF

• Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population

  Håvard Thøgersen, Bjørn Møller Pedersen, Linn Merete Åsli, Sameer Bhargava, Rune Kvåle, Lars Fjellbirkeland, Trude Eid Robsahm, Stein Aaserud, Ronnie Babigumira, Inger Kristin Larsen

  376-383

  Published: 2020-04-02

  • PDF

• Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis

  Luís Nunes, Kristine Aasebø, Lucy Mathot, Viktor Ljungström, Per-Henrik Edqvist, Magnus Sundström, Anca Dragomir, Per Pfeiffer, Adam Ameur, Fredrik Ponten, Artur Mezheyeuski, Halfdan Sorbye, Tobias Sjöblom, Bengt Glimelius

  417-426

  Published: 2023-10-21

  • PDF

• Satisfaction with care and adherence to treatment when using patient reported outcomes to individualize follow-up care for women with early breast cancer – a pilot randomized controlled trial

  Cathrine L. Riis, Pernille T. Jensen, Troels Bechmann, Sören Möller, Angela Coulter, Karina D. Steffensen

  444-452

  Published: 2020-04-02

  • PDF

• Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer

  Anne Dyhl-Polk, Merete Vaage-Nilsen, Morten Schou, Kirsten Kjeldgaard Vistisen, Cecilia Margareta Lund, Thomas Kümler, Jon Michael Appel, Dorte Lisbet Nielsen

  475-483

  Published: 2020-04-02

  • PDF

• Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study

  Lotte Keikes, Miriam Koopman, Martijn M. Stuiver, Valery E. P. P. Lemmens, Martijn G. H. van Oijen, Cornelis J. A. Punt

  395-403

  Published: 2020-04-02

  • PDF

• Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma

  Justin C. Moser, Guo Wei, Sarah V. Colonna, Kenneth F. Grossmann, Shiven Patel, John R. Hyngstrom

  434-437

  Published: 2020-04-02

  • PDF

• Impact of age on bladder cancer management practices: a general population study

  Sandrine D. Plouvier, Jean-Louis Bonnal, François Machuron, Pierre Colin, Olivier Vankemmel, Xavier Leroy, Alain Duhamel, Arnauld Villers, Fabien Saint, David Pasquier

  462-466

  Published: 2020-04-02

  • PDF